Recursion Pharmaceuticals Inc (RXRX) is higher by Thursday morning, with the stock increasing 2.13% in pre-market trading to 7.2. RXRX's short-term technical score of 49 indicates that the stock has traded less bullishly over the last month than 51% of stocks on the market. In the Biotechnology industry, which ranks 127 out of 146 industries, Recursion Pharmaceuticals Inc ranks higher than 68% of stocks. Recursion Pharmaceuticals Inc has risen 32.77% over the past month, closing at $5.23 on November 2. During this period of time, the stock fell as low as $5.23 and as high as $7.77. RXRX has an average analyst recommendation of Buy. The company has an average price target of $15.29.
RXRX has an Overall Score of 56. Find out what this means to you and get the rest of the rankings on RXRX!